Sort
326,823 grants matching “clinical trial”
GVL without GVHD across HLA barriers: Translational Studies
$1,927,639Megan Sykes · Columbia University Health Sciences · P01 · FY2010 · CA
Pediatric Fungal Network STudy of Rare Invasive Fungal DisEases in Immunocompromised Pediatric Patients (PFN-STRIDE)
$1,927,578Brian T Fisher · Children'S Hosp Of Philadelphia · U54 · FY2025 · AI
Clinical and Mechanistic Investigations of Salivary Gland Dysfunction
$1,927,479Blake Warner · National Institute Of Dental & Craniofacial Research · ZIA · FY2025 · DE
Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1
$1,927,304Katharine June Bar · University Of Pennsylvania · U01 · FY2024 · AI
Development of Novel Therapeutic Strategies in Human Leukemias
$1,927,163Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2022 · CA
Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease
$1,927,027Victor John Thannickal · University Of Alabama At Birmingham · P01 · FY2015 · HL
U OF TEXAS HLTH SCI CTR HOUSTON CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCES
$1,926,846David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2010 · RR
Growth Factor Imaging and Photoimmunotherapy
$1,926,705Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Clinical and Behavioral Phenotyping of Autism and Related Disorders
$1,926,685Susan Swedo · National Institute Of Mental Health · ZIA · FY2010 · MH
Emory-MSSM-GSK-NIMH Collaborative Mood and Anxiety Disorders Initiative
$1,926,617Helen S Mayberg · Emory University · U19 · FY2009 · MH
Refinement and Expansion of the Palliative Care Research Cooperative Group (PCRC)
$1,926,591Jean S Kutner · Duke University · U24 · FY2016 · NR
Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations
$1,926,146Sandra Ann Springer · Yale University · U01 · FY2024 · DA
Clinical Trials of Biodefense Vaccines (Dengue)
$1,926,128Stephen Whitehead · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody
$1,925,827Andrew B Norman · University Of Cincinnati · U01 · FY2020 · DA
Development of a recombinant protein vaccine for Chlamydia trachomatis
$1,925,693Toni Darville · Univ Of North Carolina Chapel Hill · U01 · FY2025 · AI
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$1,925,677Peter Karl Sorger · Harvard Medical School · U54 · FY2022 · CA
A novel therapeutic to ameliorate chronic pain and reduce opiate use
$1,925,647Boris Tabakoff · Lohocla Research Corporation · UH3 · FY2023 · DA
Community-Based VCT Tanzania
$1,925,570Michael D Sweat · Medical University Of South Carolina · U01 · FY2009 · MH
Innate Immunity: Elucidation/Modulation - Cancer Therapy
$1,925,557Ohio State University · P01 · FY2005 · CA
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease
$1,925,544Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG
Biology and Therapy of High Risk Neuroblastoma
$1,925,523Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2014 · CA
SWOG Network Group Operations Center of the NCTN
$1,925,494Charles D. Blanke · Oregon Health & Science University · U10 · FY2023 · CA
DCTD Animal Support
$1,925,432David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION
$1,925,423Bruce D Walker · Massachusetts General Hospital · U01 · FY2006 · AI
Personalized therapeutics for inhibiting breast cancer metastasis
$1,925,413Debra Auguste · City College Of New York · DP2 · FY2012 · CA